Approvals/TGA/SalplusF Inhaler 125/25 fluticasone propionate/salmeterol (as xinafoate) 125 microgram/25 microgram inhalation pressurised aerosol can metered dose

Approved

STANDARD

SalplusF Inhaler 125/25 fluticasone propionate/salmeterol (as xinafoate) 125 microgram/25 microgram inhalation pressurised aerosol can metered dose

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: a9e38fad37f2d3fd
Company: Cipla Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: a9e38fad37f2d3fd
Product Name: SalplusF Inhaler 125/25 fluticasone propionate/salmeterol (as xinafoate) 125 microgram/25 microgram inhalation pressurised aerosol can metered dose
Artg Id: 267104
Artg Name: SalplusF Inhaler 125/25 fluticasone propionate/salmeterol (as xinafoate) 125 microgram/25 microgram inhalation pressurised aerosol can metered dose
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2016-12-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-CMI-02156-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-02885-1

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

a9e38fad37f2d3fd

Type

Standard

Back to TGA Approvals